Oppenheimer Maintains Outperform Rating on IDEX, Raises Target to $280
Oppenheimer maintained its Outperform rating on IDEX and raised its price target to $280 per share from $275.
Related stories
Impedimed Posts Q1 Revenue of A$3.8 Million
M impact | EQUITY | Oct 30, 2026, 01:32 AM UTC
Eoptolink Tech Shares Fall More Than 11%
M impact | EQUITY | Oct 30, 2026, 01:32 AM UTC
DXN Posts Q1 FY27 Revenue of A$3.4 Million
DXN reported Q1 FY27 revenue of A$3.4 million.
M impact | EQUITY | Oct 30, 2026, 01:32 AM UTC
Shanghai Composite Falls Below 3,600 in Morning Trading
L impact | EQUITY | Oct 30, 2026, 01:31 AM UTC
Timberland Bancorp Q4 Earnings Snapshot
Timberland Bancorp reported net income for its fiscal fourth quarter.
M impact | EQUITY | Oct 30, 2026, 01:31 AM UTC
Asian session market picture: S&P 500 -0.99%, Nasdaq 100 -2.3%; USD/JPY -0.19%, WTI +0.77%, 1810 leads volume
Asian session market picture. US index futures: S and P futures is down 0.99 percent, Nasdaq futures is down 2.3 percent, Dow futures is down 0.14 percent and Russell futures is do
M impact | EQUITY | Oct 30, 2026, 01:30 AM UTC